Literature DB >> 9798792

Efficacy and effectiveness issues in the NIDA Cooperative Agreement: interventions for out-of-treatment drug users. National Institute on Drug Abuse.

F Rhodes1, M M Wood, R E Booth.   

Abstract

This paper examines the Cooperative Agreement (CA) HIV intervention studies for active drug users, sponsored by the National Institute on Drug Abuse, in terms of the constructs of prevention efficacy and effectiveness. A rationale is presented for conservatively interpreting outcome findings of these studies as indicative of intervention efficacy, as opposed to effectiveness. It is argued that the CA studies fall more within the domain of efficacy owing to the high degree of control and optimization that occurred with respect to intervention recruitment, participation, process monitoring, and staff training. Because the interventions were implemented and evaluated in community-based, noninstitutional settings with many real-world constraints, it is suggested that minimal shrinkage of their effects would occur if they were implemented in uncontrolled community settings. The relationship of intervention structure, content, process, dose, and participant characteristics to intervention efficacy is reviewed and discussed, both in general terms and with reference to the CA studies.

Entities:  

Mesh:

Year:  1998        PMID: 9798792     DOI: 10.1080/02791072.1998.10399701

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  2 in total

1.  Gender and risk behaviors for HIV and sexually transmitted infections among recently released inmates: A prospective cohort study.

Authors:  Ingrid A Binswanger; Shane R Mueller; Brenda L Beaty; Sung-joon Min; Karen F Corsi
Journal:  AIDS Care       Date:  2013-11-22

Review 2.  The health impacts of exposure to indoor air pollution from solid fuels in developing countries: knowledge, gaps, and data needs.

Authors:  Majid Ezzati; Daniel M Kammen
Journal:  Environ Health Perspect       Date:  2002-11       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.